Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool
The current screening test for prostate cancer (PCa) has the weak point of a high false-negative rate and a low true positive rate. There is an extreme need for a new and accurate testing system. Circulating Tumor Cells (CTCs) as the main liquid biopsy components provide excellent biomarkers for ear...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Urology Research Center
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/e4a7a1e2bb81432fba647a281a2133e2 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|